Retrospective analysis assesses fenfluramine's safety and effectiveness in epilepsy syndromes, indicating important treatment insights.
To assess the age stratified and adjunctive therapy specific effectiveness and safety of fenfluramine in patients with Dravet and Lennox Gastaut syndromes using retrospective comparative analysis of trial and open label extension data from 2018 to 2024.
No takes yet. Share an insight, caveat, or question.
Beniwal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: